Medical Devices Startups
6,236 companies tagged Medical Devices, with their investors and founders.
InformAI develops AI-guided clinical solutions for oncology and diagnostic imaging to improve patient treatment outcomes. The company specializes in radiation oncology dose prediction, with their RadOncAI platform designed to optimize head and neck radiation therapy planning while reducing exposure to healthy tissues.
2 investors
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
2 investors
Inner Cosmos develops a minimally invasive brain-computer interface, described as a "digital pill," aimed at treating depression. The company is running an FDA-approved clinical trial and has published human study results on patients with depression.
2 investors
Wellbore Tech develops imaging technology for the oil and gas sector, drawing on expertise in both energy and medical device development.
2 investors
Innoblative Designs develops a medical device for breast-conserving therapy, focused on treating breast cancer during surgical procedures. The company operates in the medtech sector.
2 investors
InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.
2 investors
Insignia Technologies develops products using patented colour-changing inks and films that provide real-time visual indicators for applications such as patient safety and food waste reduction. Founded as a spinout from the University of Strathclyde, the company serves businesses across sectors including healthcare and food.
2 investors
Instalabel develops AI tools for radiology and patient care that make artificial intelligence observable and controllable for radiologists. The company builds medical AI solutions focused on healthcare applications.
2 investors
Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.
2 investors
Insulet develops automated insulin delivery systems designed for people with diabetes to reduce daily management burden. The company serves the diabetes community globally with technology that enables greater freedom and independence in disease management.
2 investors
Commercializing rapid DNA analysis technology for forensics; acquired by Thermo Fisher Scientific in 2018.
2 investors
Intelligent Observation provides a subscription-based hand hygiene compliance monitoring system for hospitals, using near-field magnetic induction (NFMI) smart badges and a cloud dashboard to replace manual visual observation. The system aims to reduce healthcare-acquired infections and create safer environments for patients and staff.
2 investors
Interface Bio develops immunotherapies targeting complex inflammatory diseases by combining biological evolution, metabolomics, and machine learning to discover natural-derived therapeutic products.
2 investors
Align Technology develops dental technology for orthodontic treatment, including clear aligners and intraoral scanners used to straighten teeth. It uses 3D printing, aligner materials, and software algorithms to plan digital tooth movement for patients and orthodontic professionals.
2 investors
iOmx Therapeutics is a biotech company developing novel cancer therapies. Based in Munich's Martinsried biotech hub, the company focuses on transforming cancer treatment through scientific research and collaborative innovation.
2 investors
A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.
2 investors
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
2 investors
iosBio develops oral, thermostable vaccine candidates using its ESD platform, with a lead program (OraPro-EBV) targeting Epstein-Barr Virus. The company operates in the biotechnology and vaccine development sector.
2 investors
Irazú Oncology develops cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform based on engineered bacterial nanoparticles that deliver cancer antigens. The biotech company, founded in 2022, is building a pipeline of immunotherapies for cancer patients.
2 investors
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
2 investors
Iridex makes laser systems, EndoProbe handpieces, and vitreoretinal surgical consumables used for precision eye surgery in hospitals and ambulatory surgery centers. Its products serve ophthalmic surgeons in operating-room settings.
2 investors
Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes. The company serves hospitals and emergency care settings in the United States, focusing on reducing cryptogenic strokes and enabling guideline-directed patient care.
2 investors
Jeisys is a company focused on aesthetic and medical treatment products, presenting itself as a global provider open to partnerships and product inquiries. The page provides limited concrete detail beyond a focus on treatment-related offerings and worldwide connections.
2 investors
Joerns manufactures integrated beds, surfaces, and lifts designed to improve clinical outcomes and reduce caregiver injury risk in healthcare settings. The company positions its products as a cohesive system to enhance workforce stability, patient care quality, and financial performance for healthcare facilities.
2 investors